Page 38 - Nifty50

IndiaMART jumps 6% as Q3 collections beat estimates; brokerages bullish

Around 11:30 am, the IndiaMART InterMesh stock was trading 2.68 per cent higher at ₹2,201, even as the benchmark BSE Sensex was down 0.75 per cent at 81,565.86.

Hexaware Tech shares slip 3% after senior management personnel resigns

The selling pressure on the counter came after the company's president and global head of banking and the North America Hunting Team tendered his resignation

Oberoi Realty target price cut by brokerages; check Q3 results, outlook

Oberoi Realty reported that its consolidated net profit grew 0.7 per cent on year to ₹623 crore in Q3, compared to ₹618.4 crore in the same period a year ago

DCM Shriram slips 3% on posting decline in Q3 profit YoY; check details

In Q3FY26, DCM Shriram reported an 18.8 per cent fall in profit after tax (PAT) to ₹212.6 crore, as against ₹262.1 crore year-on-year (Y-o-Y)

Cyient DLM shares drop 5% post Q3; worst appears to be behind, say analysts

Cyient DLM reported a 2.18 per cent rise in net profit to ₹11.23 crore for the quarter ended December 2025, compared with ₹10.99 crore in the same quarter last year

ICICI Securities retains 'Add' on United Spirits despite Q3 volume pressure

ICICI Securities on United Spirits: Despite volume pressure, USL reported steady revenue growth, aided by premiumisation.

Brokerages bullish on ITC Hotels after Q3; see strong growth ahead

In Q3, ITC Hotels reported a 9.4 per cent increase in its consolidated net profit to ₹235.13 crore, as compared to ₹214.9 crore. On a quarter-on-quarter (Q-o-Q) basis, net profit jumped 77 per cent

CreditAccess Grameen surges 9% as stock bags upgrades post Q3 results

CreditAccess Grameen reported a positive performance in Q3FY26, with consolidated revenue rising 8 per cent year-on-year (Y-o-Y) to ₹1,490 crore from ₹1,380 crore

Stocks to watch, Jan 21: Dr Reddys, Eternal, Persistent Sys, United Spirits

Stocks to watch today, Wednesday, January 21, 2026: Cyient DLM, Shoppers Stop, HDFC Bank, Tata Steel, and Vikram Solar are among other key stocks to track today.

LTIMindtree shares slide 7% as near-term margin pressures worry investors

Analysts broadly agree that execution on large deals, margin discipline and progress on the CEO's strategic priorities will be key to driving growth beyond the current fiscal.

Nifty sinks below 25,300, Sensex lowest in 3 months: Why are markets down?

US President Donald Trump's claims over Greenland have added to global uncertainty, pressuring stock markets worldwide, analysts said

Ola Electric shares drop 7% as CFO resigns; Stock slides 24% in 10 sessions

The EV maker later announced the appointment of Deepak Rastogi as its chief financial officer, effective January 20, 2026

JK Cement surges 5% on strong volume growth, upbeat brokerage views

In its latest note, Choice Institutional Equities reaffirmed its 'Buy' rating on JK Cement, assigning a target price of ₹7,200, implying major upside from prevailing levels.

Tips Music shares soar 11% after Q3 earnings beat; JM Fin upgrades target

Consolidated net profit of Tips Music jumped 32.63 per cent Y-o-Y to ₹58.65 crore, while revenue from operations increased 21.4 per cent to ₹94.28 crore during the quarter

Unicommerce jumps 8% on partnering with Saudi-based Naqel Express

The buying interest followed Unicommerce Esolutions' announcement of a partnership with Naqel Express to strengthen logistics support for e-commerce brands across Saudi Arabia

Bajaj Electricals shares zoom 11% on foray into new business; details

Bajaj Electricals share price was in demand after the company announced its entry into 'wires' as a new business line.

Deepak Nitrite jumps 6% as arm starts second hydrogenation plant in Gujarat

The stock was in demand after the company's subsidiary, Deepak Chem Tech, commissioned its Nitration and second Hydrogenation Plant at Dahej, Gujarat

Tata Capital shares hit record as analysts hike target after Q3 results

Tata Capital posted a 36 per cent year-on-year (Y-o-Y) rise in profit to ₹1,285 crore in the October-December quarter from ₹922 crore in the year-ago period

Zydus Lifesciences upgraded to 'Buy' at Systematix; check target here

Systematix said the recent US FDA approval of Zycubo, a Menkes disease treatment marketed by Sentynl Therapeutics, significantly enhances the company's growth outlook

Analysts bullish on L&T Finance amid strong Q3 growth, profitability gains

Emkay Global has upgraded the stock to 'Buy' from 'Reduce,' on the back of improved visibility on asset quality, profitability, and expansion opportunities.